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Location is everything
A 
specifi  c isoform of casein 
kinase 1 (CK1) localizes 
to the centrosome to pro-
mote neurite extension, Greer and 
Rubin reveal.
The signaling protein Wnt-3a 
stimulates rapid neurite outgrowth 
from certain cell lines by activat-
ing the effector proteins Dishevelled 
(Dvl) 2 and 3. Dvl proteins’ down-
stream effects can be modulated by 
phosphorylation. After fi  nding that Dvl-2 and -3 were phospho-
rylated during Wnt-3a–induced neurite extension, Greer and Ru-
bin screened a panel of small molecule inhibitors to identify the 
responsible protein kinases.
IC261, an inhibitor of the closely related CK1 isoforms 
  and  , blocked Wnt-3a–induced neurite outgrowth and Dvl-2/3 
phosphorylation. Knocking down either kinase by RNAi also 
reduced Dvl-2/3 phosphorylation, yet the two isoforms had 
opposing effects on neurite formation. Cells lacking CK1  no 
longer grew neurites in response to Wnt-3a, whereas CK1  
depletion prompted neurite extension in the absence of Wnt ligand, 
suggesting that this isoform usually inhibits neurite growth.
Greer and Rubin found that, unlike CK1 , CK1  localized 
strongly to the centrosome, an organelle that controls neurite 
outgrowth in many types of neurons. Blocking this localization 
prevented Wnt-3a from inducing neurite extension. CK1  was 
targeted to the centrosome by a region in its C terminus; substi-
tuting this centrosomal localization signal for the C-terminal domain 
of CK1  allowed that isoform to promote neurite formation in 
place of CK1 , indicating that location is the key determinant of 
the isoforms’ different activities.
Many Wnt signaling pathway proteins localize to centrosomes. 
The authors now want to investigate whether they cooperate with 
CK1  to drive neurite outgrowth and other centrosome functions 
such as ciliogenesis.
Greer, Y.E., and J.S. Rubin. 2011. J. Cell Biol. doi:10.1083/jcb.201011111.
Connecting the cytokinesis dots
L
aporte et al. describe how 
precursors of the cytokinetic 
contractile ring assemble at 
the cell equator.
As fi   ssion yeast enter mitosis, 
protein clusters called cytokine-
sis nodes form around the cell cortex 
at the future site of cell division. The 
nodes eventually coalesce into a con-
tractile ring to separate daughter cells, 
but little is known about the nodes’ 
initial assembly, except that their lo-
calization at the cell cortex is determined by Mid1, a homologue of 
the animal–cell cleavage furrow protein anillin.
Laporte et al. analyzed the composition of cytokinesis nodes 
in different mutant backgrounds to defi  ne two protein modules that 
assemble around Mid1 at the plasma membrane. The fi  rst module 
consisted of the myosin light chain Cdc4 and the actin-bundling 
IQGAP protein Rng2, which together recruited the myosin motor 
protein Myo2. The second module incorporated the membrane-
bending F-BAR protein Cdc15. Both modules recruited the actin-
nucleating formin Cdc12 into the nodes, Laporte et al. found.
The researchers then used a single-molecule imaging tech-
nique called SHREC to examine how these components are orga-
nized within each cytokinesis node. Myo2’s head domain points 
into the cell interior, an orientation that may help it capture and 
pull actin fi  laments nucleated from neighboring nodes as the sep-
arate clusters condense into a full contractile ring. Senior author 
Jian-Qiu Wu now wants to examine how the organization of the 
node proteins changes as they form the contractile ring. He’s par-
ticularly interested in whether Myo2 polymerizes into fi  laments, 
as has been observed in the contractile ring of other organisms.
Laporte, D., et al. 2011. J. Cell Biol. doi:10.1083/jcb.201008171.
Clusters of Myo2 (green) 
form at the equator of 
wild-type cells (top) but 
not cells lacking the 
IQGAP Rng2 (bottom).
Osteoblasts are bone idle without Frizzled-9
T
he Wnt receptor Friz-
zled-9 (Fzd9) promotes 
bone formation, Albers 
et al. report, providing a poten-
tial new target for the treatment 
of osteoporosis.
Adult bones are maintained 
by a balance of bone-forming 
osteoblasts and bone-resorbing 
osteoclasts. Although Wnt sig-
naling affects this balance in mice and humans, the Wnt receptors 
involved remain unknown. Albers et al. found that the Wnt receptor 
Fzd9 was upregulated during osteoblast differentiation and that mice 
lacking Fzd9 had fragile bones due to low rates of bone formation.
Fzd9-null osteoblasts differentiated normally, but they failed 
to mineralize their extracellular matrix. The loss of Fzd9 disrupted 
a non-canonical branch of the Wnt signaling pathway, resulting in 
reduced levels of the transcription factor STAT1, which was, in turn, 
required for the expression of several interferon-regulated genes. 
One of these genes encoded a ubiquitin-like molecule called Isg15. 
Though little is known about Isg15’s function, restoring its expression 
in Fzd9-null osteoblasts boosted matrix mineralization, whereas mice 
lacking Isg15 had similar bone defects to Fzd9-knockout animals.
Mice lacking one copy of Fzd9 also had low bone mass, sug-
gesting that insuffi  cient Fzd9 may cause the reduced bone density 
seen in Williams-Beuren syndrome patients, who have a hemizygous 
deletion of the chromosomal region that includes the FZD9 gene. 
Senior author Thorsten Schinke now wants to investigate whether 
boosting Fzd9 expression has the opposite effect to Fzd9 depletion 
and can stimulate bone formation. If so, Fzd9 would be an attractive 
drug target for treating a variety of bone-loss disorders.
Albers, J., et al. 2011. J. Cell Biol. doi:10.1083/jcb.201008012.
CK1 (green) localizes to the 
centrosome (red), where it 
promotes neurite outgrowth 
in response to Wnt-3a.
Compared to wild-type (left), a 
vertebra from a Fzd9-null mouse 
(right) shows reduced calcein 
staining (green), indicating a 
decreased rate of bone formation.